Get started
Author

Tussawan Asakij

Observed institution: Lampang Cancer Hospital
ORCID: 0000-0003-3906-9980
Observed ORCID: 0000-0003-3906-9980
OpenAlex ID: A5027967263
A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
2019 · Siriwan Tangjitgamol, Ekkasit Tharavichitkul, et al. · Journal of Gynecologic Oncology · 89
PDF
Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial
2021 · Chokaew Tovanabutra, Tussawan Asakij, et al. · Asian Pacific Journal of Cancer Prevention · 17
PDF
Cost–utility analysis of adjuvant chemotherapy after concurrent chemoradiation in patients with locally advanced cervical cancer
2020 · Kanisa Rongsriyam, Siriwan Tangjitgamol, et al. · Journal of Medical Imaging and Radiation Oncology · 5
Head and Neck Cancer of Unknown Primary: A Multicenter Retrospective Cohort study in Northern Thailand, an Endemic Nasopharyngeal Cancer Area
2024 · Pichit Sittitrai, Donyarat Ruenmarkkaew, et al. · Asian Pacific Journal of Cancer Prevention · 3
PDF
Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial
2022 · Tussawan Asakij, Jakkapan Khunnarong, et al. · Asian Pacific Journal of Cancer Prevention · 3
PDF
286 Image-guided brachytherapy (IGBT) utilization rate from 14 radiotherapy centers in Thailand*
2024 · Ekkasit Tharavichitkul, Imjai Chitapanarux, et al. · Radiotherapy and Oncology
Works count: 6
Citation count: 117
H-index: 3
I10-index: 2
Year
Topic
Type